SlidesetViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2023African CDC - Growing Portfolio of Hepatitis-Related Activities - Hanna Amanuel Tesfahunei, MSc.pdfView Slideset
SlidesetViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2023Assessment of Hepatocellular Carcinoma Differences in Urban and Rural Africa Through Satellite Imaging Analysis - Jose Debes.pdfView Slideset
SlidesetViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2023A Global Action Agenda for Turning the Tide on Fatty Liver Disease - Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD.pdfView Slideset
SlidesetViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2023A New Player in the Management of Liver Disease in Sub-Saharan Africa - The Tanzania IR Experience - Erick Mbuguje, MD.pdfView Slideset
PDPaolo DentiPhDSlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023A (PK) Study in Scarlet: Investigating Target Concentrations | Paolo DentiView Slideset
CMCatia MarzoliniPharmD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023Short Versus Extended Nirmatrelvir/R Treatment Course and Ensitrelvir: How Do DDIs Differ? | Catia MarzoliniView Slideset
ACAndrea CalcagnoMD, DTM&HSlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023Opening Lecture: News in Antiviral Pharmacology: A Year in Review | Andrea CalcagnoView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023Short Versus Extended Nirmatrelvir/R Treatment Course and Ensitrelvir: How Do DDIs Differ? | Catia Marzolini,View Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023Pharmacokinetics of Sofosbuvir-Based Direct Acting Antivirals for HCV in Pregnancy | Catherine ChappellView Slideset
CCCatherine ChappellMD, MScSlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023Pharmacokinetics of Sofosbuvir-Based Direct Acting Antivirals for HCV in Pregnancy | Catherine ChappellView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023Temporal Changes in Dolutegravir and Raltegravir Glucuronide Metabolite to Parent Ratios | Tim CresseyView Slideset
CFCharles FlexnerMDSlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023Tissue-Specific Pharmacology Knowledge and Knowledge Gaps | Charles FlexnerView Slideset
